AGILENT TECHNOLOGIES, INC. (NYSE:A) Files An 8-K Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition.
attached hereto is furnished and shall not be deemed filed for
purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, nor shall it be deemed incorporated by reference in any
filing under the Securities Act of 1933, as amended.
issued its press release announcing financial results for the
first>fiscal quarter ended January 31, 2017. A copy of this
press release is attached as Exhibit 99.1.
meaningful supplemental information regarding our operational
performance and to enhance our investors overall understanding of
our core current financial performance and our prospects for the
future. We believe that our investors benefit from seeing our
results through the eyes of management in addition to the GAAP
presentation. Management measures segment and enterprise
performance using measures such as those that are disclosed in
this release. This information facilitates managements internal
comparisons to the Companys historical operating results and
comparisons to competitors operating results. Non-GAAP
information allows for greater transparency to supplemental
information used by management in its financial and operations
decision making. Historically, we have reported similar non-GAAP
information to our investors and believe that the inclusion of
comparative numbers provides consistency in our financial
reporting.
for, generally accepted accounting principles in the United
States. It excludes items, such as restructuring and
amortization, that may have a material effect on the Companys
expenses and earnings per share calculated in accordance with
GAAP. Management monitors these items to ensure that expenses are
in line with expectations and that our GAAP results are correctly
stated but does not use them to measure the ongoing operating
performance of the Company. The non-GAAP information we provide
may be different from the non-GAAP information provided by other
companies.
Exhibit 99.1.
not be deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, nor shall it be deemed
incorporated by reference in any filing under the Securities Act
of 1933, as amended:
|
Exhibit No.
|
Description
|
|||||
|
99.1
|
Press release announcing financial results for the
first fiscal quarter ended January 31, 2017 |
|||||
About AGILENT TECHNOLOGIES, INC. (NYSE:A)
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio. AGILENT TECHNOLOGIES, INC. (NYSE:A) Recent Trading Information
AGILENT TECHNOLOGIES, INC. (NYSE:A) closed its last trading session down -0.13 at 50.39 with 3,546,878 shares trading hands.
